Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Agitation and Stirring in Ointment Production – V 2.0

Posted on By

SOP for Agitation and Stirring in Ointment Production – V 2.0

Procedure for Agitation and Stirring in Ointment Production

Department Production/Quality Assurance (QA)/Engineering
SOP No. SOP/Ointment/038
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a systematic process for agitation and stirring during ointment production. Proper agitation ensures homogeneity, prevents ingredient separation, and maintains product consistency.

2. Scope

This SOP applies to all personnel involved in the stirring and agitation of ointments at various stages of manufacturing, including pre-mixing, emulsification, cooling, and final mixing.

3. Responsibilities

  • Production Supervisor: Ensures agitation is conducted as per specified parameters.
  • Machine Operator: Monitors stirring speed, direction, and duration.
  • Quality Assurance (QA) Personnel: Verifies compliance with GMP and product consistency.
  • Engineering Technician: Maintains and calibrates stirring and agitation equipment.
See also  Ointments: SOP for Conducting Risk Assessments in Ointment Development - V 2.0

4. Accountability

The Production and QA Managers are accountable for ensuring that agitation and stirring processes comply with GMP guidelines and are properly documented.

5. Procedure

5.1 Pre-Stirring Preparations

  • Ensure all mixing tanks and agitators are clean and sanitized.
  • Verify that the stirring equipment is calibrated and functional.
  • Confirm that all raw materials have been added to the vessel as per the Batch Manufacturing Record (BMR).

5.2 Agitation Parameters

  • Set the initial stirring speed according to the formulation requirements.
  • Use low-speed stirring for pre-mixing and high-speed agitation for emulsification.
  • Maintain agitation at a controlled temperature to prevent ingredient degradation.

5.3 Agitation and Stirring at Different Stages

5.3.1 Pre-Mixing Stage

  • Use slow-speed stirring (e.g., 50-100 RPM) to blend initial ingredients.
  • Ensure uniform dispersion of waxes, oils, and emulsifiers.
  • Monitor for clumps or undissolved particles.

5.3.2 Emulsification Stage

  • Increase stirring speed (e.g., 500-1000 RPM) to achieve uniform emulsification.
  • Monitor temperature closely to prevent phase separation.
  • Ensure stable emulsion formation by maintaining the mixing speed for a minimum of 30 minutes.
See also  Ointments: SOP for Pre-Manufacturing Area Cleaning - V 2.0

5.3.3 Cooling and Final Mixing Stage

  • Reduce stirring speed gradually to avoid air entrapment.
  • Ensure continuous stirring (e.g., 100-300 RPM) until the mixture reaches the final temperature.
  • Check homogeneity through viscosity and particle size analysis.

5.4 Monitoring During Agitation

  • Monitor stirring speed at defined time intervals.
  • Check for uniformity by visually inspecting the batch.
  • Ensure there is no excessive foaming or aeration.

5.5 Completion of Agitation

  • Reduce mixing speed to a complete stop.
  • Inspect the final product for uniform consistency.
  • Record all agitation parameters before batch transfer.

5.6 Documentation and Approval

  • Record all agitation parameters in the Agitation Log.
  • QA must review and approve the batch before further processing.
  • Label the batch as “Agitated and Ready for Next Stage.”

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • RPM – Revolutions Per Minute
  • BMR – Batch Manufacturing Record
See also  Ointments: SOP for Monitoring Mixing Speeds - V 2.0

7. Documents

  • Agitation Log (Annexure-1)
  • In-Process Quality Control Report (Annexure-2)

8. References

  • WHO GMP Guidelines for Pharmaceutical Manufacturing
  • 21 CFR Part 211 – Current Good Manufacturing Practices
  • ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Agitation Log

Date Batch Number Stage Stirring Speed (RPM) Time (Min) Verified By
01/02/2025 SOP/Ointment/001 Pre-Mixing 100 20 QA Officer
02/02/2025 SOP/Ointment/002 Final Mixing 500 30 QA Officer

Annexure-2: In-Process Quality Control Report

Date Batch Number Test Parameter Specification Result Final Status
01/02/2025 SOP/Ointment/001 Viscosity 1000-2000 cP 1500 cP Pass
02/02/2025 SOP/Ointment/002 Phase Separation None None Pass

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: SOP for Updating Documentation Based on Regulatory Changes
Next Post: SOP for Preclinical Study Data Review Meetings

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

English
 - 
en
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version